Is CBRX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

369 people get CBRX articles and Market Currents by email alert.

Get email alerts on CBRX »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Columbia Laboratories Inc.: Recent Events Lead To An Opportune Entry Point
JDBloomington • Fri, Dec 21, 2012 • 1 Comment
Columbia Labs Shares Are A Speculative Buy Here
GuruFundPicks • Tue, Jan 24, 2012 • 3 Comments

To learn more about Seeking Alpha Pro, click here.

Speculative Bio Stocks For Investors
Stock Investor • Wed, May 8 • 4 Comments
Speculative Biotech Stocks That Could Bounce, Part 2
BuySellShort • Wed, Feb 13 • 5 Comments
Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch
Scott Matusow • Fri, Mar 30, 2012 • 23 Comments
Aria And Talon: Is An Advisory Panel Meeting A Profitable Trading Catalyst?
BinaryLeverage • Sun, Mar 4, 2012 • 11 Comments
Biopharma Drug Approval Watch List
Scott Matusow • Mon, Feb 27, 2012 • 13 Comments
Behavioral Finance Lessons From Magic Formula Investors
Value Research • Sun, Feb 26, 2012 • 9 Comments
Magic Formula?
Dark-Liquidity • Tue, Feb 7, 2012 • 16 Comments
Analysis Of Noteworthy Institutional 5% Ownership Filings Tuesday And Wednesday
GuruFundPicks • Thu, Feb 2, 2012 • 1 Comment
12 Healthcare Companies Expecting Major February Catalysts
Spencer Knight • Wed, Feb 1, 2012 • 8 Comments
5 Pharma Setbacks This Week
The Burrill Report • Sun, Jan 29, 2012 • 1 Comment
Finding Opportunities Among Tuesday's Big News Movers
GuruFundPicks • Wed, Jan 18, 2012 • 5 Comments
7 Healthcare Stocks With January Catalysts
Spencer Knight • Tue, Jan 3, 2012 • 2 Comments
8 Healthcare Stocks With Unusually High P/E Ratios
Kinetic Investments • Thu, Dec 29, 2011 • 3 Comments
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
David Zanoni • Mon, Dec 12, 2011 • 3 Comments
Greenblatt's Magic Formula Portfolio Quarterly Update
Value Research • Wed, Nov 30, 2011
Biotech Focused Hedge Fund RA Capital's Top Q3 Picks
GuruFundPicks • Sun, Nov 20, 2011 • 3 Comments
3 Stocks Under $3 With Impressive Profitability
Kapitall • Wed, Nov 16, 2011 • 2 Comments
Small Cap Biotech: Top Buy And Sell Ideas Based On Last Week's Big News, Price Movers
GuruFundPicks • Mon, Sep 19, 2011 • 2 Comments
5 Healthcare Company Updates Released Wednesday
Alex Shadunsky • Thu, Jul 28, 2011 • 2 Comments
Upcoming PDUFA Dates for Sub-$5 Stocks
Alex Shadunsky • Tue, Jul 5, 2011 • 6 Comments

Columbia Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 9
Columbia Laboratories Management Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 14
Columbia Laboratories Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 8, 2012
Columbia Laboratories's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Fri, Aug 10, 2012 • 1 Comment
Columbia Laboratories, Inc. Q4 2008 Earnings Call Transcript
Thu, Mar 19, 2009
Columbia Laboratories, Inc. Q3 2008 Earnings Call Transcript
Wed, Nov 19, 2008
Columbia Laboratories, Inc. Q2 2008 Earnings Call Transcript
Fri, Sep 5, 2008

Class Action Lawsuit against Columbia Laboratories Dismissed without Prejudice

Business Wire (Jun 12, 2013)
Columbia Laboratories Reports First Quarter 2013 Financial Results

Business Wire (May 9, 2013)
Columbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9 Conference Call

Business Wire (Apr 25, 2013)
Columbia Laboratories Extends Agreement with Merck Serono for CRINONE Ex-U.S. into 2020

Business Wire (Apr 9, 2013)
Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results

Business Wire (Mar 14, 2013)
Columbia Laboratories Extends Stockholder Rights Plan to Preserve Use of Net Operating Losses under Section 382

Business Wire (Mar 6, 2013)
Columbia Laboratories to Discuss Fourth Quarter and Year-End 2012 Financial Results on March 14 Conference Call

Business Wire (Mar 4, 2013)
Columbia Laboratories to Present March 6th at Cowen and Company Health Care Conference

Business Wire (Feb 28, 2013)
Jonathan B. Lloyd Jones Appointed CFO of Columbia Laboratories

Business Wire (Jan 16, 2013)
Columbia Laboratories Reports Third Quarter 2012 Financial Results

Business Wire (Nov 8, 2012)
Columbia Laboratories Expects Ongoing Email and Phone Outages into Next Week

Business Wire (Nov 1, 2012)
Columbia Laboratories Confirms FDA Denies Watson’s Appeal Related to Prochieve NDA for the Prevention of Preterm Birth

Business Wire (Oct 26, 2012)
Columbia Laboratories to Discuss Third Quarter 2012 Financial Results on November 8 Conference Call

Business Wire (Oct 25, 2012)
Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter

Business Wire (Oct 25, 2012)
Columbia Laboratories Regains Compliance with Nasdaq Listing Standards

Business Wire (Sep 6, 2012)
Columbia Laboratories Will Present on September 6 at Stifel Nicolaus Healthcare Conference

Business Wire (Aug 23, 2012)
Columbia Laboratories Reports Second Quarter 2012 Financial Results

Business Wire (Aug 8, 2012)
Columbia Laboratories to Discuss Second Quarter 2012 Financial Results on August 8, 2012, Conference Call

Business Wire (Jul 25, 2012)
Columbia Laboratories Reports First Quarter 2012 Financial Results

Business Wire (May 4, 2012)
Columbia Laboratories to Discuss First Quarter 2012 Financial Results on May 4 Conference Call

Business Wire (Apr 24, 2012)

CBRX vs. ETF Alternatives

Company Description

Currently, there's no company description for CBRX.

Sector: Healthcare

Industry: Drug Delivery & Accessories

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 9, 9:55 AM Columbia Laboratories (CBRX): Q1 EPS of $0.01 misses by $0.02. Revenue of $6.3M misses by $0.2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, March 14, 7:00 AM Columbia Laboratories (CBRX): Q4 EPS of $0.01 misses by $0.01. Revenue of $7.1M misses by $0.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, January 16, 1:36 PM Columbia Labs (CBRX +1.4%) gets a small lift today after saying it's appointed Jonathan B. Lloyd Jones as Vice President, Finance, CFO, Treasurer and Secretary, effective January 21. Lloyd recently served as CFO and vice president of corporate development at biotech firm TetraLogic Pharmaceuticals. Comment! [Healthcare]
Thursday, November 8, 2012, 6:55 AM Columbia Laboratories (CBRX): Q3 EPS of $0.02 beats by $0.01. Revenue of $6.7M (+35% Y/Y) misses by $0.3M. (PR) Comment! [Earnings, Healthcare]
Friday, October 26, 2012, 3:36 PM Specialty pharmaceutical company Columbia Laboratories (CBRX -41%) gets clobbered today after the FDA denies Watson Pharmaceuticals (WPI -0.5%) formal dispute-resolution request related to its new-drug application for Prochieve, a treatment for the prevention of preterm birth. Watson said it intends to review possible options to continue pursuit of the the drug's development. Comment! [Healthcare, On the Move]
Friday, October 26, 2012, 12:45 PM Midday top 10 gainers: DV +25%. AMCC +24%. RCON +21%. TASR +18%. NEU +17%. STMP +16%. VAR +16%. ELMD +14%. N +14%. TSYS +15%. Midday top 10 Losers: CBRX -42%. CTCT -26%. MXWL -23%. HMSY -21%. VRSN -19%. REDF -16%. DECK -18%. UQM -17%. IPCM -16%. BJRI -15%. Comment! [On the Move]
Friday, October 26, 2012, 9:10 AM Premarket gainers: EXPE +16%. PPC +11%. ACI +10%. GALE +6%. JRCC +6%. LOGI +6%.
Losers: CBRX -28%. CTCT -22%. DECK -19%. VRSN -17%. IMOS -15%. SPF -6%. ERIC -5%. CSTR -5%. Comment! [On the Move]
Tuesday, March 13, 2012, 7:21 AM Columbia Laboratories (CBRX) has reportedly hired Cowen to help it explore potential strategic transactions. Comment! [Healthcare]
Monday, February 27, 2012, 8:10 AM Shares of Columbia Laboratories (CBRX) move down 4.1% premarket after the FDA rejects the use of its Prochieve gel used to reduce the risk of preterm births. (previous) Comment! [Healthcare, On the Move]
Tuesday, January 24, 2012, 11:24 AM Canaccord Genuity weighs in on Columbia Laboratories (CBRX +2.2%) after the firm was rocked by a FDA rejection of its preterm birth prevention gel. Though analyst Randall Stanicky acknowledges the "disappointment," he still sees potential for CBRX and rival Watson Pharmaceuticals (WPI -3.4%) on possible M&A activity and the under-leveraged balance sheets the firms carry. Comment! [On the Move, Healthcare]
Monday, January 23, 2012, 8:17 AM Columbia Labs (CBRX) -52.5% premarket after trading was suspended all day Friday following the FDA's negative vote on the company's Prochieve drug candidate. Partner Watson Pharmaceutials (WPI) is little changed after falling 3.5% on Friday. Rival K-V (KV.A) +1.9% after Friday's 9.3% gain. Comment! [Healthcare, On the Move]
Friday, January 20, 2012, 3:17 PM Shares of K-V Pharmaceutcial (KV.A +10.4%) rally as rival Columbia Laboratories (CBRX) gets raked over the coals by the FDA in a review of its preterm birth gel that ends up concluding the firm's data isn't sufficient. (previous: I, II). Trading on CBRX still halted. Comment! [On the Move, Healthcare]
Friday, January 20, 2012, 10:43 AM While shares of Columbia Laboratories (CBRX) remain in Never-Never land - halted since premarket - reports tip off that the FDA is ripping apart the firm's reproductive health drug at an ongoing panel meeting. Comment! [Healthcare]
Friday, January 20, 2012, 8:21 AM Shares of Columbia Laboratories (CBRX) are halted in premarket trading pending a FDA committee discussion of the firm's progesterone gel aimed at reducing the risk of preterm births. Comment! [Healthcare]
Wednesday, January 18, 2012, 9:10 AM Premarket gainers: UEPS +31%. CVM +16%. CBRX +16%. KUTV +11%. LLTC +8%. ZLTQ +7%. NBG +7%. WFR +5%. ING +4%. FRO +4%. HEK +3%. STM +3%. YHOO +3%. OMX +3%.
Losers: PSLV -10%. RIMM -6%. PCX -5%. CREE -4%. FAST -4%. BK -3%. BGLS -3%. GEN -3%. Comment! [On the Move]
Tuesday, January 17, 2012, 1:43 PM Trading Columbia Labs (CBRX -22.9%) is halted as word spreads that the FDA has said that the firm's preterm birth gel isn't effective. Shares were in a dizzying freefall before the halt kicked in. Comment! [On the Move, Healthcare]

losteniraq
I got an email last week, claiming CBRX will likely reach 1.25 by the end of next month, we'll see...
3/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Stockmarketdouble
CBRX really undervalued here
2/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Endrix
To many short trader on CBRX it'll drive away other trader, vol hit below 1M.
2/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Endrix
will CBRX going up again?
1/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Day Trader001
CBRX did have some bad news today, but is now priced low enough to ride the fluctuation. Hit it and go to the bank!
1/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
Buying $CBRX at $1.08 and lower with a target gain of $0.35 Will likely hold most overnight
1/17/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Kudrna
Updated FDA Calendar $SPY $IWM $QQQ $CBRX $BIIB $ELN $BMY $BMY $LLY $ALKS http://bit.ly/zyfS5U
1/5/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Columbia Laboratories (CBRX) continues to rise after Jim Cramer's Street.com article. http://tinyurl.com/2e2nmvp
12/27/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Baby bios on the move as CBRX announces positive clinical trial results. Hitting new highs: CBRX, ZGNX, ONCY, SURG (on 12x vol & no news).
12/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
ZIOP, NBY, EBS, ABT, PRXL, CERN, ACT, CBRX => Notable Developments and Results 12/6/10 => Rx Investors.com => http://bit.ly/c9Kc5C
12/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

CBRX Columbia Laboratories, Inc.

CBRX

Columbia Laboratories, Inc.